Really important to note this. There may be the usual fears around B.1.617 because people will see a paper with "x-fold reduction in neutralizing antibodies" etc. Keep in mind that drop DOES NOT correspond even to reduced efficacy, let alone ability to prevent severe cases.https://twitter.com/VincentRK/status/1391869808858238979 …
-
Show this thread
-
Replying to @zeynep
As an immunologist, who is also working with these mutants and immune response, I completely agree with you.
1 reply 4 retweets 53 likes
Replying to @DeryaTR_
Yes, immunologists are always trying to correct this, but people keep running with the "x-fold reduction" headline as if it corresponds to clinical x-fold reduction in efficacy or something like that. Needlessly scaring people.
10:59 AM - 11 May 2021
1 reply
4 retweets
36 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.